Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study
| Conditions: | Mesothelioma |
| Start Date: | February 1, 2008 |
| Phase: | Phase II|Phase III |
| Status: | Recruiting |
| NCT ID: | NCT00651456 |
| Study Type: | Interventional |
| Intervention: | Drug: Standard Chemotherapy (Pemetrexed and Cisplatin)|Drug: Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab |
| Study Design: | Allocation: Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Intergroupe Francophone de Cancerologie Thoracique|University Hospital, Caen|Groupe Francais De Pneumo-Cancerologie |
| Ages: | Adult|Senior |
| Enrollment: | 445 |
| Funded By: | Other |
| First Received: | March 29, 2008 |
| End Date: | November 1, 2012 |
| Last Updated: | April 28, 2010 |
| Last Verified: | April 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
